For Immediate Release
Contact: Mindy Cooper, Animas Corporation
610-644-8990, ext. 1157
Animas Corporation Introduces Its Next Generation Insulin Pump
March 21, 2007 - West Chester, PA - The convergence of new technology and diabetes management is reaching new heights with the introduction of the Animas® 2020 insulin pump. Developed by Animas Corporation, the Animas® 2020 is the first insulin pump to feature an Organic Light-Emitting Diode (OLED) display screen that allows for brighter, clearer images. OLED is the same technology used in today's televisions, digital cameras, PDAs and virtual reality headsets.
The new screen is just one of several features included in the pump design to help make diabetes management easier for the 1.5 million people who control their diabetes with intensive insulin therapy.
The smallest full-featured pump on the market today, the Animas® 2020 pump enables users to adjust their insulin based on food intake and activity level in the smallest fraction available (0.025 U/hr). By utilizing the pump's 500 food database, users have the tools they need to help achieve greater insulin dosing accuracy. Other highlights include waterproof at 12 feet for 24 hours, the ability to store blood glucose and carbohydrate values and editor features for greater personalization.
"The Animas® 2020 pump embodies the wants and needs of our users," explains Audrey Finkelstein, Executive Vice President Worldwide, Clinical and Government Affairs. "Pump users, diabetes experts, doctors and engineers worked together to design a pump that puts safety, superior performance, convenience - and ease-of-use - at the forefront. Because living with diabetes is 24/7, the pump's self-illuminating, high-contrast color screen for easier viewing - day or night - was a must-have for our patients."
Animas Corporation, a Johnson & Johnson company, (www.animascorp.com) is dedicated to making diabetes management easier through product innovation, exceptional customer support and customized education programs. The Animas® 2020 insulin pump is the company's fifth generation insulin pump since the company was founded in 1996. In addition to insulin pumps, the company markets ancillary products for insulin pump therapy. The company was acquired by Johnson & Johnson in February 2006.
Last Updated: Wednesday November 05, 2014 21:27:23
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2016. Comments and Feedback.